News - Page 369

TLDR: Key Points: Rapid Liquid Print, a MIT spin-off, raised $7 million for its liquid-based 3D printing technology. The funding round was led by Germany’s HZG Group, BMW i Ventures, and MassMutual.

TLDR: Botanix Labs raised $8.5 million in a seed round to build a Bitcoin-native DeFi ecosystem. The funds will be used to develop the Spiderchain, a Bitcoin-native Layer 2 primitive with full

TechCrunch Article Summary TLDR: Key Points: TechCrunch is part of the Yahoo family of brands When using their sites and apps, cookies are used for various purposes Summary: The article discusses how

TLDR: – Niobium secures $5.5 million in venture financing to commercialize FHE accelerator chip – The company is revolutionizing Zero Trust Computing with its innovative cryptography hardware Niobium, a leading custom silicon

TLDR: Octopus Energy receives new investment from Generation Investment Management and Canada Plan Investment Board, pushing valuation over $9bn This marks a total of over $2bn raised from global investors in just

TLDR: Daloopa, an AI-powered historical data provider, raised $18M in Series B funding. The funding will be used to innovate proprietary algorithms, improve data quality in financial services, and expand into new

Summary of GlassWing Equity’s “Venture Equity” Investment Model TLDR: GlassWing Equity introduces innovative “Venture Equity” investment model. The model prioritizes outstanding human talent for sustainable, long-term success. Today, GlassWing Equity unveiled its

TLDR: The United Arab Emirates plans to invest up to $1 billion in South Korean startups through a joint venture with AIM Global Foundation and LB Investment. This investment is part of

TLDR: – Wiz lands $1 billion in funding at a $12 billion valuation from major Silicon Valley venture capital firms – The funding comes as Wiz sees surging growth in the cloud

TLDR: Zenas BioPharma announced an upsized $200 million Series C preferred stock financing led by SR One, Norwest Venture Partners, and Delos Capital. The financing will support mid- to late-stage clinical development